EUVIMEDEUVIMED entdecken
Crossref

Complement-Mediated Renal Thrombotic Microangiopathy Associated with Anti-Vascular Endothelial Growth Factor and Immune Checkpoint Inhibitor Therapy Successfully Treated with Eculizumab

Qiuling Fan

Journal of the American Society of Nephrology · 2026-10 · 37 (10S)

DOI: 10.1681/asn.2026knxp56ce ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Qiuling Fan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Fan, Q. (2026). Complement-Mediated Renal Thrombotic Microangiopathy Associated with Anti-Vascular Endothelial Growth Factor and Immune Checkpoint Inhibitor Therapy Successfully Treated with Eculizumab. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.2026knxp56ce

Vancouver

Fan Q. Complement-Mediated Renal Thrombotic Microangiopathy Associated with Anti-Vascular Endothelial Growth Factor and Immune Checkpoint Inhibitor Therapy Successfully Treated with Eculizumab. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.2026knxp56ce

BibTeX
@article{Fan2026,
  author = {Fan, Qiuling},
  title = {Complement-Mediated Renal Thrombotic Microangiopathy Associated with Anti-Vascular Endothelial Growth Factor and Immune Checkpoint Inhibitor Therapy Successfully Treated with Eculizumab},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  volume = {37},
  number = {10S},
  doi = {10.1681/asn.2026knxp56ce}
}
Kostenlos starten →